Ulrich Moebius has joined MorphoSys AG as head of preclinical development and project management. Previously he was head of preclinical development at Medigene AG.
Prior to working at Medigene, he spent five years with the Deutsches Krebsforschungszentrum (German Cancer Research Centre) in Heidelberg and two years at the Dana-Farber Cancer Institute in Boston, Massachusetts, US. Dr Moebius has a PhD in immunology from the Johannes Gutenberg University Mainz and qualified as a professor in immunology at the University of Heidelberg.
At MorphoSys he will help oversee an expansion of the company’s proprietary drug pipeline.
Copyright 2009 Evernow Publishing Ltd